DE602004029946D1 - Verfahren zur Klassifizierung der Genexpressions-Stärke in Lungenkrebsgeweben. - Google Patents

Verfahren zur Klassifizierung der Genexpressions-Stärke in Lungenkrebsgeweben.

Info

Publication number
DE602004029946D1
DE602004029946D1 DE602004029946T DE602004029946T DE602004029946D1 DE 602004029946 D1 DE602004029946 D1 DE 602004029946D1 DE 602004029946 T DE602004029946 T DE 602004029946T DE 602004029946 T DE602004029946 T DE 602004029946T DE 602004029946 D1 DE602004029946 D1 DE 602004029946D1
Authority
DE
Germany
Prior art keywords
gene expression
lung cancer
cancer tissues
expression strength
classifying gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004029946T
Other languages
English (en)
Inventor
Takashi Takahashi
Shuta Tomita
Tetsuya Mitsudomi
Yasushi Yatabe
Nobuhiko Ogura
Masato Some
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Aichi Prefecture
Original Assignee
Fujifilm Corp
Aichi Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Aichi Prefecture filed Critical Fujifilm Corp
Publication of DE602004029946D1 publication Critical patent/DE602004029946D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602004029946T 2003-12-12 2004-12-10 Verfahren zur Klassifizierung der Genexpressions-Stärke in Lungenkrebsgeweben. Active DE602004029946D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003415119A JP5192632B2 (ja) 2003-12-12 2003-12-12 肺癌組織中の遺伝子発現強度を識別する方法

Publications (1)

Publication Number Publication Date
DE602004029946D1 true DE602004029946D1 (de) 2010-12-16

Family

ID=34510569

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602004029946T Active DE602004029946D1 (de) 2003-12-12 2004-12-10 Verfahren zur Klassifizierung der Genexpressions-Stärke in Lungenkrebsgeweben.
DE602004005650T Active DE602004005650T2 (de) 2003-12-12 2004-12-10 Verfahren zur klassifizierung der genexpressionsstärke in lungenkrebsgeweben

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602004005650T Active DE602004005650T2 (de) 2003-12-12 2004-12-10 Verfahren zur klassifizierung der genexpressionsstärke in lungenkrebsgeweben

Country Status (4)

Country Link
US (3) US7856318B2 (de)
EP (3) EP1541698B1 (de)
JP (1) JP5192632B2 (de)
DE (2) DE602004029946D1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5192632B2 (ja) * 2003-12-12 2013-05-08 愛知県 肺癌組織中の遺伝子発現強度を識別する方法
WO2006121207A1 (en) * 2005-05-12 2006-11-16 Oncotherapy Science, Inc. Methods for damaging cells using effector function of anti-dsc2 antibody
US8969000B2 (en) 2007-06-01 2015-03-03 Agendia B.V. Prognostic gene expression signature for non small cell lung cancer patients
WO2012149014A1 (en) 2011-04-25 2012-11-01 OSI Pharmaceuticals, LLC Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
JP6841429B2 (ja) * 2015-08-03 2021-03-10 国立大学法人東海国立大学機構 未分化間葉系幹細胞マーカー及びその用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002044331A2 (en) * 2000-11-29 2002-06-06 Cangen International Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
IL157872A0 (en) * 2001-03-12 2004-03-28 Monogen Inc A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
EP1444361A4 (de) * 2001-09-28 2006-12-27 Whitehead Biomedical Inst Klassifizierung von lungenkarzinomen mittels genexpressionsanalyse
US20040063120A1 (en) 2002-07-10 2004-04-01 The Regents Of The University Of Michigan Expression profile of lung cancer
JP5192632B2 (ja) * 2003-12-12 2013-05-08 愛知県 肺癌組織中の遺伝子発現強度を識別する方法
WO2006053442A1 (en) * 2004-11-22 2006-05-26 Diagnocure Inc. Calml3 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis

Also Published As

Publication number Publication date
EP1541698A2 (de) 2005-06-15
DE602004005650D1 (de) 2007-05-16
JP5192632B2 (ja) 2013-05-08
US20110081652A1 (en) 2011-04-07
US20130303389A1 (en) 2013-11-14
EP1541698B1 (de) 2007-04-04
EP1795615B1 (de) 2010-11-03
EP2295605B1 (de) 2012-08-22
EP2295605A1 (de) 2011-03-16
US7856318B2 (en) 2010-12-21
EP1795615A2 (de) 2007-06-13
EP1795615A3 (de) 2007-09-26
JP2005261201A (ja) 2005-09-29
US20050170386A1 (en) 2005-08-04
EP1541698A3 (de) 2005-07-13
DE602004005650T2 (de) 2007-12-27
US8244478B2 (en) 2012-08-14

Similar Documents

Publication Publication Date Title
ATE504521T1 (de) Verfahren zur zubereitung von getränken
ATE440888T1 (de) Verfahren zur herstellung von glatiramer
DE602004022130D1 (de) Verfahren zur Zeichenerkennung
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
DE602004009676D1 (de) Verfahren zur Musikklassifikation
DE602006015090D1 (de) Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
ATE479409T1 (de) Verfahren zur herstellung von saugkernen
DE112005001904A5 (de) Verfahren zur Bestimmung relevanter Objekte
DE602005021839D1 (de) Drehbare Sonde un Verfahren zur Reinigung von Hohlräumen
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE502005001997D1 (de) Verfahren zur herstellung von silanisierten kohlenstoff-nanoröhren
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE502006002680D1 (de) Verfahren zur herstellung von feinteiligem c.i. pigment red 254
DE502005002018D1 (de) Verfahren zur Formung von Signalspektren
ATE417839T1 (de) Verfahren zur herstellung von amorolfin
DE602004029946D1 (de) Verfahren zur Klassifizierung der Genexpressions-Stärke in Lungenkrebsgeweben.
DE502004007419D1 (de) Verfahren zur Herstellung von Radschüsseln
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen